Manalo, Meljie M.
HRN: 20-44-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2023
CEFTRIAXONE 1G (VIAL)
09/12/2023
09/18/2023
IVT
750mg
Q12
Subperiosteal Abscess Right, Csom Ad
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes